DC Klonoff - Diabetes Care, 2005 - ncbi.nlm.nih.gov 1: Diabetes Care. 2005 May;28(5):1231-9. Continuous glucose monitoring: roadmap for 21st
century diabetes therapy. Klonoff DC. Mills-Peninsula Health Services Diabetes Research Institute,
100 S. San Mateo Dr., Rm. 3124, San Mateo, CA 94401, USA. klonoff@itsa.ucsf.edu. ... Cited by 171 - Related articles - All 3 versions
- ►diabetesjournals.org B Guerci, M Floriot, P Böhme, D Durain, M … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The analysis was conducted on 18 type 1 diabetic patients
(not controlled, HbA 1c >7.5%) treated by external pump using insulin analogs. Each patient
received a glucose sensor for 3 days during his/her hospitalization and was instructed in ... Cited by 117 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org M Metzger, G Leibowitz, J Wainstein, B Glaser, I … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 11 subjects (6 type 1 and 3 type 2 diabetic
patients and 2 healthy subjects) agreed to wear two sensors and perform at least four daily
finger-stick glucose determinations during 72 h. The simultaneous glucose values ... Cited by 105 - Related articles - BL Direct - All 5 versions
E Renard - Current Opinion in Pharmacology, 2002 - Elsevier Although subcutaneous insulin infusion from portable pumps is the current optimal therapy for
type 1 diabetic patients, implantable pumps using the intraperitoneal route allow increased blood
glucose stability and lowered incidence of severe hypoglycemia. Subcutaneously ... Cited by 64 - Related articles - All 3 versions
S Davis, MD Alonso - Journal of Diabetes and its Complications, 2004 - Elsevier Diabetes mellitus is associated with significant morbidity and mortality derived from long-term
microvascular and macrovascular complications of chronic hyperglycemia. The Diabetes Control
and Complications Trial (DCCT) and the UK Prospective Diabetes Study (UKPDS) have ... Cited by 59 - Related articles - All 12 versions
A Poscia, M Mascini, D Moscone, M Luzzana, G … - Biosensors and …, 2003 - Elsevier The performances and the stability of a novel subcutaneous glucose monitoring system have
been evaluated. GlucoDay® (A. Menarini IFRSrl, Florence Italy) is a portable instrument provided
with a micro-pump and a biosensor coupled to a microdialysis system capable of ... Cited by 34 - Related articles - All 4 versions
- ►diabetesjournals.org C Choleau, P Dokladal, JC Klein, WK Ward, GS Wilson, … - Diabetes, 2002 - Am Diabetes Assoc Due to the lag between sugar intake and the beginning of recovery from hypoglycemia, it is necessary
to intervene in an anticipatory way if one wants to prevent, not only detect, hypoglycemia. This
article presents the principle of a hypoglycemia prevention system based on risk ... Cited by 30 - Related articles - BL Direct - All 11 versions
- ►ispad.org [PDF] JJ Robert - Hormone research, 2000 - content.karger.com Continuous blood glucose monitoring aims to: better evaluate glycaemic variations; better detect
hypoglycaemia; and, ultimately, automatize insulin delivery (artificial cell). The sensors can be
fully implantable, with the challenge of constructing durable systems to avoid repeated ... Cited by 30 - Related articles - BL Direct - All 10 versions
B Leboulanger, RH Guy, MB Delgado-Charro - Physiological measurement, 2004 - iop.org 1 School of Pharmacy, University of Geneva, 30, Quai Ernest-Ansermet CH-1211 Geneva 4,
Switzerland 2 Centre international de recherche et d'enseignement ('Pharmapeptides'), F-74160
Archamps, France ... E-mail: richard.guy@pharm.unige.ch ... Received 3 October 2003, ... Cited by 29 - Related articles - BL Direct - All 12 versions
